UX007
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for UX007, covering 2019-02-08 to 2021-02-11. Get the full timeline:
Most recent: Clinical Trial Update: A Study of UX007 (Triheptanoin) in Participants With Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) [Phase 2]